NCT00672373View on ClinicalTrials.gov

Extract of Ginkgo Biloba and Tardive Dyskinesia

PHASE3CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

August 31, 2007

Conditions
Tardive DyskinesiaSchizophrenia
Interventions
DRUG

Extract of Ginkgo Biloba (EGb-761 capsules)

EGb-761 240mg/d, 1 capsule(80mg) tid,po,12 weeks; Each capsule contains 19.6mg flavonol glycosides and 4.8mg terpene lactones.

DRUG

Placebo

Wheat flour placebo capsule,1 capsule tid, po,12 weeks

Trial Locations (1)

100096

Beijing Hui-Long-Guan Hospital, Beijing

All Listed Sponsors
collaborator

Peking University

OTHER

lead

Beijing HuiLongGuan Hospital

OTHER

NCT00672373 - Extract of Ginkgo Biloba and Tardive Dyskinesia | Biotech Hunter | Biotech Hunter